跳至主要内容
临床试验/NCT04803214
NCT04803214已完成不适用

ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

Mainstay Medical53 个研究点 分布在 1 个国家目标入组 203 人开始时间: 2021年7月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
203
试验地点
53
主要终点
Change in Oswestry Disability Index (ODI)

研究概览

简要总结

This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).

详细描述

This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM), where OMM means the patient is managed according to available guideline-directed treatments (e.g., medication, physical therapy, injections) individualized to meet the patient needs. All patients who satisfy the enrollment criteria are randomized (1:1) to receive either ReActiv8 (Treatment group) or OMM (Control group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥21 years
  • Evidence of lumbar multifidus muscle dysfunction
  • Intractable Chronic Low Back Pain that has persisted >6 months resulting in pain most of the days in the past 12 months
  • Failed therapy including pain medications and physical therapy
  • Not a candidate for spine surgery
  • Low Back Pain NRS of ≥6 and ≤9
  • Oswestry Disability Index score ≥30 and ≤60
  • Willing and capable of giving Informed Consent
  • Able to comply with this protocol
  • On Optimal Medical Management per the Investigator

排除标准

  • Contraindicated for the ReActiv8 System
  • Any surgical correction procedure for scoliosis at any time, or a current clinical diagnosis of moderate to severe scoliosis
  • An independent MRI assessment identifying a pathology that is likely the cause of the CLBP and is amenable to surgery
  • Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain) below the knee
  • Any condition unrelated to CLBP which, in the opinion of the Investigator, could limit physical movement or compliance with the protocol, or interfere with the assessment of efficacy
  • Surgical and other procedure exclusions
  • Psycho-social exclusions
  • Protocol compliance exclusions
  • General exclusions

研究组 & 干预措施

Treatment (ReActiv8)

Active Comparator

Market-approved ReActiv8 device

干预措施: ReActiv8 (Device)

Control (OMM)

No Intervention

Optimized medical management (OMM) (Standard of Care)

结局指标

主要结局

Change in Oswestry Disability Index (ODI)

时间窗: 1 year

Comparison of 1-year change from baseline in ODI between Treatment and Control with MMRM for missing data. ODI is measured on a scale of 0 to 100 where a lower score is a better outcome.

次要结局

  • Change in Low Back Pain Numerical Rating Scale (LBP NRS)(1 year)
  • Change in EQ-5D(1 year)

研究者

发起方
Mainstay Medical
申办方类型
Industry
责任方
Sponsor

研究点 (53)

Loading locations...

相似试验